ResearcherMokpo National UniversityActive in the last 2 years
Eun‐Young Park
Matched on ORCID iD 0000-0002-4263-201X; OpenAlex author ID A5100695847. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 2
2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 4
- Oxidative stress and pancreatic cancer: a dual role in tumorigenesis and drug toxicity. Last author DOI 10.1007/s43188-025-00301-3↗
- Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential. Last author DOI 10.1186/s12935-024-03535-7↗
- Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells. Last author DOI 10.3390/molecules27103346↗
- Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. Last author DOI 10.3390/molecules27238127↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Khem Raj Limbu · 3 shared papers, 2022–2025 · strength 0.75
- Paper Oxidative stress and pancreatic cancer: a dual role in tumorigenesis and drug toxicity. DOI 10.1007/s43188-025-00301-3↗
- Paper Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential. DOI 10.1186/s12935-024-03535-7↗
- Paper Mebendazole Impedes the Proliferation and Migration of Pancreatic Cancer Cells through SK1 Inhibition Dependent Pathway. DOI 10.3390/molecules27238127↗
- Su Bin Kim · 1 shared paper, 2022 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.